→
Baxter International Inc currently trades at $17.30, down 2.70% from the previous close of $17.78, reflecting significant weakness as the company faces a year-over-year revenue decline of 4.79%. With a market cap of $8.93B and a troubling return on equity of -16.43%, the fundamentals suggest further downside potential, especially given the current price is 46.06% below its 52-week high of $32.04.
I recommend a cautious stance on Baxter International Inc, as the combination of declining revenue and poor profitability metrics points to continued challenges ahead.
If Baxter can pivot successfully, it might benefit from the projected $5.46B global IV fluid bags market, which is expected to grow at a CAGR of 6.8% by 2035. Additionally, the recent earnings beat of $0.36 against an estimate of $0.31 could indicate potential for improved performance in upcoming quarters.
The company's return on equity of -16.43% signals deep inefficiencies, which could deter investors amidst declining revenues. Furthermore, the consensus of 1 Strong Buy, 4 Buy, and 16 Hold ratings suggests a lack of conviction in a turnaround, with the majority leaning towards caution.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates BAX as Bearish. I recommend a cautious stance on Baxter International Inc, as the combination of declining revenue and poor profitability metrics points to continued challenges ahead.
The company's return on equity of -16.43% signals deep inefficiencies, which could deter investors amidst declining revenues. Furthermore, the consensus of 1 Strong Buy, 4 Buy, and 16 Hold ratings suggests a lack of conviction in a turnaround, with the majority leaning towards caution.
If Baxter can pivot successfully, it might benefit from the projected $5.46B global IV fluid bags market, which is expected to grow at a CAGR of 6.8% by 2035. Additionally, the recent earnings beat of $0.36 against an estimate of $0.31 could indicate potential for improved performance in upcoming quarters.
Baxter International Inc currently trades at $17.30, down 2.70% from the previous close of $17.78, reflecting significant weakness as the company faces a year-over-year revenue decline of 4.79%. With a market cap of $8.93B and a troubling return on equity of -16.43%, the fundamentals suggest further downside potential, especially given the current price is 46.06% below its 52-week high of $32.04.
Baxter International Inc currently trades at $17.30, down 2.70% from the previous close of $17.78, reflecting significant weakness as the company faces a year-over-year revenue decline of 4.79%. With a market cap of $8.93B and a troubling return on equity of -16.43%, the fundamentals suggest further downside potential, especially given the current price is 46.06% below its 52-week high of $32.04. Our overall verdict is Bearish.
Helm Terminal offers free AI-powered stock analysis for BAX at helmterminal.dev/analyze/BAX, updated continuously during US market hours. No signup required.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.